(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9

A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines

(2011) Christian Freise et al.   BMC Complementary and Alternative Medicine

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes

(2010) Christian Freise et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

NF-κB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy

(2009) Jian-Min Wu et al.   CANCER LETTERS

Insulin/IGF-1 paradox of aging: Regulation via AKT/IKK/NF-κB signaling

(2009) Antero Salminen et al.   CELLULAR SIGNALLING

The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity

(2009) Christian Freise et al.   MATRIX BIOLOGY

Caspase Activity Modulators as Anticancer Agents

(2008) Ilya Okun et al.   Anti-Cancer Agents in Medicinal Chemistry

Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells

(2008) B. C. Fuchs et al.   CANCER RESEARCH

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease

(2008) Diego F. Calvisi et al.   CARCINOGENESIS

Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-β-mediated profibrotic gene expression pattern

(2008) Martin Ruehl et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

NF-κB signaling, liver disease and hepatoprotective agents

(2008) B Sun et al.   ONCOGENE